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Background: Delirium is an acute change in cognition and concentration that complicates the postoperative course.
Patients who suffer delirium after surgery have an increased risk of persistent cognitive impairment, functional decline,
and death. Postoperative delirium is also associated with an increased length of hospital stay and higher costs. With the
goal of preventing delirium in postoperative patients, we organized a medical team from the Delirium Management
and Assessment Center (D-mac) at Okayama University Hospital in January 2012. The team members consisted of
physicians, pharmacists, nurses, and clinical psychologists.
Methods: We retrospectively reviewed the medical records of patients with delirium to examine risk factors related to
the patients’ background.
Results: Fifty-nine postoperative patients with lung or esophageal cancer were investigated; 25% exhibited delirium
during hospitalization. Multiple logistic regression analysis showed significant associations between the presence of
delirium and a past history of delirium (odds ratio, 4.22; 95% CI, 1.10-16.2; p = 0.09) and use of benzodiazepine
receptor agonists (odds ratio, 3.97; 95% CI, 1.09-14.5; p = 0.03). Intervention by the D-mac significantly reduced the
rate of delirium episodes in lung cancer patients (p =0.01). Notably, prior to intervention, the incidence of delirium
was 100% when three high-risk factors for delirium were present. In contrast, the incidence of delirium in patients
with three high-risk factors decreased following implementation of the D-mac intervention.
Conclusions: These findings suggest that active participation by various staff in the medical team managing delirium
had a marked therapeutic impact.
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Delirium is a disturbance of consciousness characterized
by changes in cognition, perceptual disturbances, and a re-
duced ability to focus, sustain, or shift attention [1]. These
symptoms typically manifest in disorientation, memory
impairment, and alteration of mental processes, which can
present as a hyperactive form, a hypoactive form, or a* Correspondence: kitamu-y@cc.okayama-u.ac.jp
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unless otherwise stated.combination of the two [2,3]. Delirium has been associ-
ated with an increase in the length of hospital stay and
complication rates, as well as functional decline [3,4]. Sev-
eral studies have investigated risk factors such as advanced
age, preoperative cognitive impairment, cephalopathy and
delirium events, and alcoholism [3,5,6].
Surgery itself may play a role in delirium [3]. Postoperative
delirium, a common and serious complication following sur-
gery, has been associated independently with prolonged
hospital stays, increased costs, and higher mortality [7].
Given this background, physicians, pharmacists, nurses
and clinical psychologists at Okayama University Hospital
(Okayama, Japan) formed a Delirium Management andtral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pated in supporting surgical patients since January 2012.
Additionally, the hospital established a Perioperative
Management Center (Perio). The Perio team (physicians,
pharmacists, nurses) actively participated in the safe peri-
operative management of lung and esophageal cancer
patients and screened for patients who had a high risk of
delirium. We defined the high-risk factors for delirium
as age (over 70), past history of cephalopathy, past history
of delirium, cognitive decline, and alcoholism [3,5,6].
The Perio then referred these high-risk patients to the
D-mac (Figure 1).
In general, delirium-inducing factors are categorized as
predisposing factors, promoting factors, or direct factors
[8]. Pharmaceuticals are considered a direct factor in the
development of a delirium episode [8]. As a prophylactic
intervention against delirium, the pharmacists in charge of
the D-mac mainly evaluated any medicines taken by the
patients as well as postoperative medications.
In the present study, we identified the predictive
factors (age (over 70), past history of cephalopathy, past
history of delirium, cognitive decline, and alcoholism)
for delirium by examining the relationship between
baseline patient characteristics and delirium in patients
with postoperative-induced delirium, particularly those
with lung and esophageal cancer. Furthermore, we con-
figured the clinical end point for the intervention of theFigure 1 Perioperative management at the Okayama University Hosp
participated in the safe perioperative management of lung and esophagea
delirium. The D-mac was composed of physicians, pharmacists, nurses, and
surgical patients at high risk of delirium.D-mac to be the incidence of delirium in this study. To
investigate the impact of intervention by the D-mac, we
examined the frequency of delirium episodes before and
after participation by the D-mac.
Methods
Patient characteristics
Data were collected retrospectively on 119 patients with
delirium in our hospital during the period from 1 January,
2011, to 31 December, 2011. We researched age, sex, the
presence or absence of surgical intervention, and the dur-
ation of delirium. Delirium was diagnosed postoperatively
by the attending physician based on the criteria of the
Diagnostic and Statistical Manual of Mental Disorders IV
edition, Text Revision (DSM-IV-TR), which are regarded
as the most inclusive criteria for delirium. The study was
conducted in accordance with the ethics committee of the
Graduate School of Medicine, Dentistry and Pharmaceutical
Sciences, Okayama University.
Effects of delirium-inducing risk factors in postoperative
patients with lung or esophageal cancer
Data on 59 preoperative patients with lung or esophageal
cancer at our hospital during the period from 30 June,
2011, to 1 January, 2012, were collected retrospectively. We
researched age, sex, disease (lung or esophageal cancer), 5
high-risk factors for delirium (age >70 years, past historyital. The Perio team (physicians, pharmacists, nurses) actively
l cancer patients and screened for patients who had a high risk of
clinical psychologists. The D-mac has actively participated in supporting
Table 1 Background of postoperative delirium patients
Number of patients 119
Sex (male female) 86:33
Mean age 70.2 (32-89)
Number of postoperative delirium patients 76
Durations of delirium events (days) 5.1 (0-59)
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history of delirium, cognitive decline, and alcoholism), and
sleep disorder as the primary symptom of delirium [9].
Furthermore, we examined the utilization of 8 classifica-
tions of high-risk drugs, as follows: (1) benzodiazepines,
(2) H2 blockers, (3) antihistamine drugs, (4) steroids. (5)
anti-cholinergic drugs with tricyclic and tetracyclic anti-
depressants, (6) anti-epileptic drugs, (7) anti-parkinson
drugs, and (8) opioids.Effects of D-mac interventions in postoperative lung
cancer patients
The present D-mac-implemented program was ini-
tially adopted by our hospital on 1 January, 2012. Data
were collected retrospectively on 88 preoperative patients
with lung cancer for the period from 1 January, 2011,
to 31 December, 2011, prior to implementation of the
D-mac interventions; 99 preoperative patients with lung
cancer who were treated from 1 January, 2012, to 31
December, 2012, provided data for the period follow-
ing implementation of the D-mac intervention. We
researched age, sex, disease, the presence or absence
of the five high-risk factors for delirium (age > 70 years,
past history of cephalopathy with cerebrovascularFigure 2 Time-dependent frequency of delirium patients after surger
The mean duration of delirium episodes was 5.1 days.disorders, past history of delirium, cognitive decline, and
alcoholism).
Statistics
Categorical variables were compared using the χ2 test.
The association between risk factors and the occurrence
of delirium was assessed using multivariate logistic re-
gression and expressed in terms of the odds ratio (OR)
and 95% confidence interval (CI). Sex, age, past history
of cephalopathy with cerebrovascular disorders, past his-
tory of delirium, cognitive decline, alcoholism, sleep dis-
orders, and medications served as covariates. Statistical
significance was defined as p <0.05.
Results
Patient background
Table 1 shows the incidence of delirium in the operative
patients. In total, 119 patients with delirium (mean age
70.9 years [range, 32–89 years]) were included in this
study. Of these, 76 patients had delirium following an
operation. The mean duration of delirium episodes was
5.1 days (range, 0–59 days). Furthermore, delirium more
often occurred within 3 days versus within 4 days after
surgery (Figure 2, Table 2). Compared with patients
exhibiting delirium within 3 days, those exhibiting
delirium after 4 days were on average younger (73.8
versus 65.8 years, respectively).
Effects of delirium-inducing factors in postoperative lung
and esophageal cancer patients
Table 3 summarizes the baseline characteristics of 59
preoperative patients with lung or esophageal cancer. The
mean age was 74.6 years (range, 44–87 years). A greatery. We investigated that 76 patients had delirium following an operation.










Mean age 43 33
Table 4 Delirium-inducing high-risk drugs
High-risk drungs Number Taking medication (%)
Benzodiazepines 29 49
H2 blockers 10 17





Antiepileptic drugs 3 5
Antiparkinson drugs 1 2
Opioids 0 0
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geal cancer (29%). Additionally, more than half (n = 36;
61%) of these patients had been treated with drugs known
to increase the risk of delirium. Delirium was diagnosed in
15 of the 59 (25%) patients during the study period.
Of the high-risk drugs for delirium, nearly half (49%)
of the patients used benzodiazepine receptor agonists
(49%) (Table 4). Patients also took H2 blockers (17%),
antihistamines (12%), and steroids (7%).
Tables 5 through 7 present the results of the logistic re-
gression analysis. A past history of delirium and the use of
benzodiazepines significantly increased the odds of post-
operative delirium (OR 4.22, 95% CI, 1.10-16.2; p = 0.03
for past history of delirium; OR 3.97, 95% CI, 1.09-14.5;
p = 0.03 for benzodiazepine use) (Tables 5 and 6). Use
of etizolam was also significantly associated with de-
lirium (p = 0.02) (Table 7).
Effect of D-mac management on delirium in postoperative
patients with lung cancer
During the period from January 2011 to December 2012,
the Perio referred 187 patients to the D-mac (Table 8).Table 3 Background of postoperative delirium of lung
and esophageal cancer patients
Number %
Number of patients 59
Sex (male female) 41:18 69:31
Mean age 74β (44-87)
Lung cancer: esophageal cancer 42:17 71:29
Delirium inducing high-risk factors Number %
Yes No
Past history of cephabpathy 22 37 37:63
Past history of delirium 12 47 20:80
Cognitive decline 11 44 20:80
Alcoholism 8 51 14:86
Sleep disorder 17 42 29:71
High-risk drugs 36 23 61:39
Postoperative delirium events Number %
Number of postoperative delirium 15 25
Sex (male: female) 12:3 80:20Since January 2012, the D-mac has actively participated
in managing surgical patients with lung and esophageal
cancer. Of the 187 patients, 88 had received interven-
tion without D-mac management between January
and December 2011. The remaining 99 patients had
received intervention with D-mac management com-
mencing in 2012. Between 2011 and 2012, the char-
acteristics of the patients did not change in terms of
age, past history of cephalopathy or delirium, cogni-
tive decline, and alcoholism. However, the number of
patients with delirium significantly decreased after
the implementation of D-mac interventions in 2012.
Furthermore, in 2011, the incidence of delirium rose
to 100% in patients who had three high-risk factors.
However, the incidence of delirium fell to 21.4% following
intervention by the D-mac (Figure 3). In patients over
75 years, delirium events occurred in 37.8% of post-
operative patients with lung cancer. However, the in-
cidence of delirium decreased to 9.4% with D-mac
intervention (Figure 3).
Discussion and conclusions
The present study demonstrated that team medical
care-implemented pharmaceutical management for the
patients contributed to a prevention in surgical patients
with lung and esophageal cancer. Furthermore, theTable 5 Relationships between patient background and
postoperative delirium events
Odds ratio 95% CI P-values
Sex (male) 2.07 0.50-8.48 0.30
Age (>70) 3.11 0.36-27.2 0.28
Lung cancer 1.87 0.45-7.69 0.38
Past history of cephalopathy 1.69 0.51-5.56 0.38
Past history of delirium 4.22 1.10-16.2 0.03
Cognitive decline 3.24 0.80-13.1 0.09
Alcoholism 0.97 0.17-5.44 0.97
Sleep disorder 2.00 0.58-6.90 0.09
Table 6 Relationship between high-risk drugs and post-
operative delirium events
High-risk drugs Odds ratio 95% CI P-values




H2 blockers 1.32 0.29-5.93 0.71
Steroids 1.32 0.29-5.93 0.24
Antihistamine drugs 0.45 0.05-4.10 0.47







Number % Number %
High-risk patients 88 47.0 99 53.0
Delirium patients 19 21.6 9 9.10 0.01
Sex
Male 57 64.7 63 63.6 0.87
Female 31 35.3 36 36.4
Mean age 71.9 (30-88) 73.8 (34-87) 0.16
Age(>70) 67 76.1 84 84.8 0.13
Past history of
cephalopathy
26 29.5 28 28.3 0.85
Past history of
delirium
10 11.4 19 19.2 0.14
Cognitive decline 5 5.7 9 9.1 0.38
Alcoholism 10 11.4 15 15.2 0.45
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gical patients with lung and esophageal cancer con-
tributed to a decrease in the incidence of delirium through
pharmaceutical care.
In general, delirium is characterized by symptoms of
disturbance in consciousness, such as disorientation,
hallucinations, and delusion [10]. Delayed improvement
in illness due to the aggravation of delirium has been re-
ported [11]. Early discovery of delirium and intervention
are desirable as one-third of delirium cases can be pre-
vented through the identification of high-risk patients
and appropriate intervention [12].
Causes of delirium are broadly categorized as predis-
posing, promoting, and direct factors. In this study,
many patients with delirium developed this condition
after surgery. As such, postoperative delirium has been
reported in about 40% of surgical patients [13,14].
‘Surgery’ is considered a predisposing factor for delirium
[3] and influences physical causes, such as pain, mental
causes, such as postoperative anxiety and depression,
and promoting factors, such as environmental changes
in an intensive care unit. The onset of postoperative de-
lirium occurred relatively early following surgery, as pre-
viously reported, and this tendency for early onset was
stronger in more elderly patients [15,16]. This suggests
that elderly surgical patients may bear a higher risk for
delirium and may therefore require early intervention
before surgery. In our study, the incidence of delirium
was higher in older patients for several days immediately
following surgery.
The D-mac at our hospital identified several high-risk
factors for delirium. Of these, ‘past medical history of
delirium’ was shown to be a significant risk factor forTable 7 Relationship between benzodiazepines and
postoperative delirium events
Drugs Number % Odds ratio 95% CI P-values
Brotizolam 12 41 1.63 0.41-6.49 0.48
Zolpidem 9 31 1.58 0.34-7.31 0.55
Etizolam 4 17 10.8 1.02-112.9 0.02postoperative delirium. The presence of a past medical
history of delirium was the only significant independent
high-risk factor. However, the incidence of delirium rose
when multiple high-risk factors were present, suggesting
the importance of confirming the presence of multiple
high-risk factors in patients before surgery. In fact, the
incidence of delirium rose to 100% in patients who had
three high-risk factors before D-mac intervention in
surgical patients in this study.
‘Drugs’ are considered to be a ‘direct factor’ causing
delirium [6], and represent causative factors for delirium
in many elderly patients [17,18]. The prevalence of
insomnia has recently increased and is particularly high
in the elderly [19]. Accordingly, commensurate with the
aging of the population in Japan, the prescription rate
for benzodiazepine receptor agonists has increased [20].
Benzodiazepine receptor agonists are well known for
inducing delirium [21-23]; these drugs were most fre-
quently brought in by patients on admission in this study.
The incidence of postoperative delirium was significantly
higher in patients who were medicated with these drugs.
Many benzodiazepine receptor agonists are mainly metab-
olized in the liver [24]. Liver and kidney functions are
generally reduced in the elderly, particularly after surgery
[13,25]. Moreover, absorption of benzodiazepine receptor
agonists is influenced by intestinal peristalsis, but this
function is reduced after surgery in many cases. Therefore,
the ability to metabolize benzodiazepine receptor agonists
may be markedly reduced postoperatively in elderly pa-
tients. The reduced metabolism and changes in absorption
may promote drug accumulation and sensitivity and
induce cognitive dysfunction, a known effect specific to
benzodiazepine receptor agonists. Given these mecha-
nisms, benzodiazepine receptor agonists are likely to cause
Figure 3 Correlation between incidence of delirium and high-risk factors and age with or without D-mac intervention. We investigated
the association of delirium episodes with hig-risk factors and age with or without D-mac intervention. Values are expressed as the incidence of
delirium patients (%). *p < 0.05, **p < 0.01, significantly different from 2011 (before D-mac intervention).
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be given to patients who are treated with these drugs prior
to surgery. Brotizolam, zolpidem, and etizolam accounted
for a large proportion of the benzodiazepine receptor
agonists brought to the hospital by patients on admission.
In particular, etizolam was significantly associated with the
development of postoperative delirium. This finding sug-
gests that etizolam should be administered to postopera-
tive elderly patients with extreme caution. Moreover, of
the three drugs, etizolam is the most lipid-soluble (distri-
bution coefficient: 354, pH 7, octanol/water) and exhibits
high potency. Benzodiazepine receptor agonists were most
frequently brought in by patients on admission. However,
it was not obvious whether delirium occurred under condi-
tions in which benzodiazepine receptor agonists were
taken or not taken in this retrospective study. Further
study is underway to clarify this point. For patients com-
plaining of insomnia and at risk for postoperative delirium,
the D-mac currently recommends prescribing trazodone
hydrochloride, which, among the triazolopyridine deriva-
tives, exerts a strong hypnotic effect but does not act on
the benzodiazepine receptor. However, the usefulness of
trazodone hydrochloride in preventing postoperative delir-
ium should be further investigated.
The incidence of postoperative delirium was signifi-
cantly reduced by the D-mac intervention team comprised
of psychiatrists, pharmacists, nurses, and clinical psychol-
ogists. This demonstrates that early identification of high-
risk factors and drugs potentially inducing delirium along
with appropriate interventions are beneficial in preventing
postoperative delirium. Since delirium may develop when
multiple risk factors are concomitantly present [17,26,27],
a comprehensive approach involving the collaboration of
an interdisciplinary team may be effective.On the other hand, the role of the ward pharmacists is
to evaluate the patient’s background characteristics and
medications brought from home and to formulate ap-
propriate recommendations based on these assessments.
When reviewing a patient’s medications on admission, it
is essential that ward pharmacists identify drugs associ-
ated wuth a high risk of delirium and advise the attending
physicians to withdraw these drugs and prescribe alterna-
tive medications. Expanding and developing the pharma-
cist’s role in this regard may assist in improving the quality
of medical care aimed at preventing delirium. In turn,
these measures may benefit the patient, and thereby
achieve an important goal of ward drug management.
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